Urgent Calls for Stronger Regulation of Illicit E-Cigarettes

Regulations by 2FIRSTS.ai

Nov.29.2023

Urgent Calls for Stronger Regulation of Illicit E-Cigarettes

Tobacco companies press for FDA regulation of illegal e-cigarettes, while Reynolds files complaint over Chinese imports.

In recent days, both British American Tobacco and Altria Group have urged the US Food and Drug Administration (FDA) to strengthen regulations on illegal synthetic nicotine e-cigarettes. Simultaneously, R.J. Reynolds Tobacco Company and Reynolds Vapor have filed a complaint with the US International Trade Commission, targeting over 25 companies involved in the illegal import of unregulated flavored disposable e-cigarette products, with a majority of these products originating from China.

Yolonda Richardson, President and CEO of the tobacco harm reduction organization, has stated that illegally distributed and unauthorized flavored products must be removed from the market. This call highlights the shared concern among all parties regarding the regulation and compliance of the e-cigarette market, aiming to ensure product quality and public health.

References:

[1] BAT launches marketing campaign to boost vaping's public health role

Also Read:

[1] Kola Karim Appointed as Chairman of BAT Nigeria's Advisory Committee

#E-cigarette #E-cigarettes and Tobacco

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Imperial Brands FY25 Results: NGP Net Revenue Up 13.7%, Americas Surges Nearly 70%

Imperial Brands reported FY25 NGP net revenue of £368 million, up 13.7% at constant currency. Growth in the Americas accelerated sharply, with NGP revenue up 69.8%, driven by the expansion of the modern oral brand Zone. Europe delivered 8.8% growth, supported by blu’s double-digit vapour share across key markets. Adjusted NGP operating losses narrowed to £76 million, putting the category closer to breakeven.

Nov.18 by 2FIRSTS.ai

Philip Morris USA Reaches $66M Settlement With Washington State Over MSA Payment Dispute

Philip Morris USA has reached a settlement with Washington State and agreed to pay $66 million to resolve disputes over annual payments under the 1998 Master Settlement Agreement (MSA) for the period 2005–2015.

Nov.04 by 2FIRSTS.ai

EU to Abstain from WHO Tobacco Treaty Vote Amid Deep Internal Split

The European Union will abstain from voting at the upcoming 11th session of the WHO Framework Convention on Tobacco Control (COP11) in Geneva, following months of internal disagreement over how to regulate tobacco and nicotine products. The decision marks a rare and public fracture in EU health policy, reportedly driven by the European Commission’s hardline anti-tobacco stance.

Nov.18 by 2FIRSTS.ai

5th Circuit Reviews FDA’s Compliance on Small-Business Impact of Vape Rule

A Fifth Circuit panel expressed doubts about whether the U.S. Food and Drug Administration complied with the Regulatory Flexibility Act when issuing its 2021 final rule on premarket tobacco product applications. Vape companies argued the FDA relied on outdated and inaccurate economic data, while the government said the challenged requirements stem from the Tobacco Control Act.